Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 326 followers
Latest posts
Last updated 7 minutes ago
FDA demands better response from Abbott over Libre inspection violations
7 minutes ago
Abbott has been hit with a slew of complaints from the FDA...
Medtronic 'steps up' with up to $585M deal for Israeli devicemaker CathWorks
18 minutes ago
Just weeks after announcing it would "step up" its acquisitions this year...
GSK's new CEO looking for $2B to $4B deals 'hiding in plain sight'
about 2 hours ago
Luke Miels had only been at the helm of GSK for 20...
Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1
about 3 hours ago
Novo Nordisk’s CEO was magnanimous about Pfizer’s victory in last year’s bidding...
Amgen advances toward lupus redemption while gastric cancer candidate struggles
about 3 hours ago
Amgen’s bad luck in lupus may finally be coming to an end...
NHS ‘FIT’ bowel cancer test reduced unnecessary referrals as cancer numbers remain stable
about 5 hours ago
England’s National Health Service’s faecal immunochemical test (FIT) has reduced referrals for...
NIH turmoil takes center stage as director acknowledges no vaccine-autism link
about 16 hours ago
National Institutes of Health Director Jayanta Bhattacharya, M.D., Ph.D., spent much of...
HHS launches $100M antiviral prize to develop broad-spectrum therapies
about 18 hours ago
While the Trump Administration may be pivoting away from certain vaccinations, it...
Charles River to close cell therapy CDMO site, lay off 20 staffers
about 21 hours ago
Charles River Laboratories is continuing its run of layoffs by announcing the...
FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases
about 22 hours ago
As the first CAR-T treatment for an autoimmune disease draws ever closer...
Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges
about 22 hours ago
Pfizer has pumped the brakes on six early-stage assets, including three being...
Fledgling biotech Exxel plans $13M IPO to succeed where other FAAH inhibitors have failed
about 22 hours ago
Exxel Pharma is eyeing a listing on the NYSE American to fund...